ALLGEIER SE NA O.N./ DE000A2GS633 /
17/05/2024 08:01:07 | Var. +0.6000 | Volume | Denaro21:50:17 | Lettera21:50:17 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
19.4500EUR | +3.18% | 0 Fatturato: 0.0000 |
-Quantità in denaro: - | -Quantità in lettera: - | 221.89 mill.EUR | 2.57% | 18.70 |
GlobeNewswire
00:11
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
00:00
ADSK Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Act...
GlobeNewswire
17/05
NCLA Tells Department of Education Its Newest Student Loan Debt Cancellation Plan Is Unlawful
GlobeNewswire
17/05
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of...
GlobeNewswire
17/05
Lincoln National Corporation investors: Please contact the Portnoy Law Firm to recover your losses; ...
GlobeNewswire
17/05
IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic ...
GlobeNewswire
17/05
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
17/05
Experience the Illicit Romance of 19th-Century with B.D. Anderson's "Forbidden Desires"
GlobeNewswire
17/05
Altus Group Terminates Proposed Acquisition of Situs Group’s Commercial Real Estate Valuation Servic...
GlobeNewswire
17/05
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
17/05
AKRO Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Akero Therapeutics, Inc. Investors wit...